The DOI matches its Crossref record; 165 of the 165 references it cites were found in a registry or an index.
Tumor Cell Metabolism Imaging
Abstract
Molecular imaging of tumor metabolism has gained considerable interest, since preclinical studies have indicated a close relationship between the activation of various oncogenes and alterations of cellular metabolism. Furthermore, several clinical trials have shown that metabolic imaging can significantly impact patient management by improving tumor staging, restaging, radiation treatment planning, and monitoring of tumor response to therapy. In this review, we summarize recent data on the molecular mechanisms underlying the increased metabolic activity of cancer cells and discuss imaging techniques for studies of tumor glucose, lipid, and amino acid metabolism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Revised Response Criteria for Malignant Lymphoma
Cheson, B. D., Pfistner, B., Juweid, M. E., Gascoyne, R. D., Specht, L., Horning, S. J., Coiffier, B., Fisher, R. I., Hagenbeek, A., Zucca, E., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.2403 · Cited by 4,426
Kim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
Menendez, J. A., & Lupu, R. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2222 · Cited by 2,941 · cited 1×
“Overexpression of FAS has been observed in many human cancers including among others breast, prostate, lung, and colorectal cancer (84), and high levels were associated with a poor prognosis (84).”
BackgroundIncrease in signal-to-noise ratio of > 10,000 times in liquid-state NMR
Ardenkjær-Larsen, J. H., Fridlund, B., Gram, A., Hansson, G., Hansson, L., Lerche, M. H., Servin, R., Thaning, M., & Golman, K. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1733835100 · Cited by 2,861
Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1.
Semenza, G. L., Roth, P. H., Fang, H. M., & Wang, G. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31580-6 · Cited by 1,897
p53 Regulates Mitochondrial Respiration
Matoba, S., Kang, J.-G., Patino, W. D., Wragg, A., Boehm, M., Gavrilova, O., Hurley, P. J., Bunz, F., & Hwang, P. M. (2006) · Science · doi:10.1126/science.1126863 · Cited by 1,650
Mutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma
Baysal, B. E., Ferrell, R. E., Willett-Brozick, J. E., Lawrence, E. C., Myssiorek, D., Bosch, A., Mey, A. V. D., Taschner, P. E. M., Rubinstein, W. S., Myers, E. N., et al. (2000) · Science · doi:10.1126/science.287.5454.848 · Cited by 1,638
Akt Stimulates Aerobic Glycolysis in Cancer Cells
Elstrom, R. L., Bauer, D. E., Buzzai, M., Karnauskas, R., Harris, M. H., Plas, D. R., Zhuang, H., Cinalli, R. M., Alavi, A., Rudin, C. M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2904 · Cited by 1,454
(2000) · PubMed · Cited by 1,445
The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation
Halestrap, A. P., & Price, N. T. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3430281 · Cited by 1,348
Laughner, E., Taghavi, P., Chiles, K., Mahon, P. C., & Semenza, G. L. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.12.3995-4004.2001 · Cited by 1,256
Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer
Macheda, M. L., Rogers, S., & Best, J. D. (2005) · Journal of Cellular Physiology · doi:10.1002/jcp.20166 · Cited by 1,229
Cancer's Molecular Sweet Tooth and the Warburg Effect
Kim, J.-W., & Dang, C. V. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1501 · Cited by 1,215
c-Myc transactivation of LDH-A : Implications for tumor metabolism and growth
Shim, H., Dolde, C., Lewis, B. C., Wu, C.-S., Dang, G., Jungmann, R. A., Dalla-Favera, R., & Dang, C. V. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.13.6658 · Cited by 1,092
Law, M., Yang, S., Wang, H., Babb, J. S., Johnson, G., Cha, S., Knopp, E. A., & Zagzag, D. (2003) · PubMed Central · Cited by 1,084
Majumder, P. K., Febbo, P. G., Bikoff, R., Berger, R., Xue, Q., McMahon, L. M., Manola, J., Brugarolas, J., McDonnell, T. J., Golub, T. R., et al. (2004) · Nature Medicine · doi:10.1038/nm1052 · Cited by 964
Day, S. E., Kettunen, M. I., Gallagher, F. A., Hu, D.-E., Lerche, M., Wolber, J., Golman, K., Ardenkjaer-Larsen, J. H., & Brindle, K. M. (2007) · Nature Medicine · doi:10.1038/nm1650 · Cited by 883
Mutations in SDHC cause autosomal dominant paraganglioma, type 3
Niemann, S., & Müller, U. (2000) · Nature Genetics · doi:10.1038/81551 · Cited by 875 · cited 1×
“Mutations of succinate dehydrogenase (SDH) and fumarate hydratase (FH) gene are associated with the development of pheochromocytomas, leiomyomas, leiomyosarcoma, and renal cell carcinoma (8,29,30).”
BackgroundGallamini, A., Hutchings, M., Rigacci, L., Specht, L., Merli, F., Hansen, M., Patti, C., Loft, A., Di Raimondo, F., D'Amore, F., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.6525 · Cited by 846
Lordick, F., Ott, K., Krause, B.-J., Weber, W. A., Becker, K., Stein, H. J., Lorenzen, S., Schuster, T., Wieder, H., Herrmann, K., et al. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70244-9 · Cited by 804
Self-citationA microenvironmental model of carcinogenesis
Gatenby, R. A., & Gillies, R. J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2255 · Cited by 721
Fatty acid synthesis: a potential selective target for antineoplastic therapy
Kuhajda, F. P., Jenner, K., Wood, F. D., Hennigar, R. A., Jacobs, L. B., Dick, J. D., & Pasternack, G. R. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.14.6379 · Cited by 705 · cited 2×
“In fact, 14Cacetate has been used for many years to quantify fatty acid synthesis in vitro (128).”
BackgroundMethodWeber, W. A., Ott, K., Becker, K., Dittler, H.-J., Helmberger, H., Avril, N. E., Meisetschläger, G., Busch, R., Siewert, J.-R., Schwaiger, M., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.12.3058 · Cited by 701
Self-citationProgress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development
Kelloff, G. J., Hoffman, J. M., Johnson, B., Scher, H. I., Siegel, B. A., Cheng, E. Y., Cheson, B. D., O'Shaughnessy, J., Guyton, K. Z., Mankoff, D. A., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2626 · Cited by 671
Fatty Acid Synthase and Cancer: New Application of an Old Pathway
Kuhajda, F. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4673 · Cited by 647
Pauleit, D. (2005) · Brain · doi:10.1093/brain/awh399 · Cited by 634
Mitochondrial tumour suppressors: a genetic and biochemical update
Gottlieb, E., & Tomlinson, I. P. M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1737 · Cited by 621
Integrated PET/CT: Current Applications and Future Directions
von Schulthess, G. K., Steinert, H. C., & Hany, T. F. (2006) · Radiology · doi:10.1148/radiol.2382041977 · Cited by 619
Aboagye, E. O., & Bhujwalla, Z. M. (1999) · PubMed · Cited by 596
Metabolic Imaging by Hyperpolarized 13C Magnetic Resonance Imaging for In vivo Tumor Diagnosis
Golman, K., Zandt, R. I., Lerche, M., Pehrson, R., & Ardenkjaer-Larsen, J. H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2564 · Cited by 591
Radiolabeled amino acids: basic aspects and clinical applications in oncology.
Jager, P. L., Vaalburg, W., Pruim, J., de Vries, E. G. E., Langen, K., & Piers, D. (2001) · PubMed · Cited by 558
Scheidler, J. E., Hricak, H., Vigneron, D. B., Yu, K. K., Sokolov, D. L., Huang, L., Zaloudek, C. J., Nelson, S. J., Carroll, P. R., & Kurhanewicz, J. V. (1999) · Radiology · doi:10.1148/radiology.213.2.r99nv23473 · Cited by 553
Howe, F. A., Barton, S. J., Cudlip, S. A., Stubbs, M., Saunders, D. E., Murphy, M., Wilkins, P., Opstad, K. S., Doyle, V. L., McLean, M. A., et al. (2003) · Magnetic Resonance in Medicine · doi:10.1002/mrm.10367 · Cited by 539
Stroobants, S., Goeminne, J., Seegers, M., Dimitrijevic, S., Dupont, P., Nuyts, J., Martens, M., van den Borne, B., Cole, P., Sciot, R., et al. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(03)00073-x · Cited by 526
Sodium-coupled neutral amino acid (System N/A) transporters of the SLC38 gene family
Mackenzie, B., & Erickson, J. D. (2004) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/s00424-003-1117-9 · Cited by 515
PET imaging of prostate cancer using carbon-11-choline.
Hara, T., Kosaka, N., & Kishi, H. (1998) · PubMed · Cited by 515
Haioun, C., Itti, E., Rahmouni, A., Brice, P., Rain, J.-D., Belhadj, K., Gaulard, P., Garderet, L., Lepage, E., Reyes, F., et al. (2005) · Blood · doi:10.1182/blood-2005-01-0272 · Cited by 494
Weber, W. A., Petersen, V., Schmidt, B., Tyndale-Hines, L., Link, T., Peschel, C., & Schwaiger, M. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.12.004 · Cited by 493
Self-citationSynthesis and radiopharmacology of O-(2-[18F]fluoroethyl)-L-tyrosine for tumor imaging.
Wester, H. J., Herz, M., Weber, W., et al. (1999) · PubMed · Cited by 466
Self-citationOtt, K., Weber, W. A., Lordick, F., Becker, K., Busch, R., Herrmann, K., Wieder, H., Fink, U., Schwaiger, M., & Siewert, J.-R. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.7801 · Cited by 464
Self-citationNew approaches for imaging tumour responses to treatment
Brindle, K. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2289 · Cited by 460
Topographic anatomy and CT correlations in the untreated glioblastoma multiforme
Burger, P. C., Heinz, E. R., Shibata, T., & Kleihues, P. (1988) · Journal of Neurosurgery · doi:10.3171/jns.1988.68.5.0698 · Cited by 452
Akt-dependent transformation: there is more to growth than just surviving
Plas, D. R., & Thompson, C. B. (2005) · Oncogene · doi:10.1038/sj.onc.1209097 · Cited by 429
The molecular machinery of Keilin's respiratory chain
Rich, P. R. (2003) · Biochemical Society Transactions · doi:10.1042/bst0311095 · Cited by 408
Chen, W., Silverman, D. H. S., Delaloye, S., Czernin, J. G., Kamdar, N. V., Pope, W. B., Satyamurthy, N., Schiepers, C. W., & Cloughesy, T. F. (2006) · PubMed · Cited by 407
Dowling, C., Bollen, A. W., Noworolski, S. M., McDermott, M. W., Barbaro, N. M., Day, M. R., Henry, R. G., Chang, S. M., Dillon, W. P., Nelson, S. J., et al. (2001) · PubMed Central · Cited by 378
Grosu, A. L., Weber, W. A., Franz, M., Stärk, S., Piert, M., Thamm, R., Gumprecht, H., Schwaiger, M., Molls, M., & Nieder, C. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.01.056 · Cited by 373
Self-citationDeGrado, T. R., Coleman, R. E., Wang, S., BALDWIN, S. W., Orr, M. D., Robertson, C. N., Polascik, T. J., & Price, D. T. (2001) · PubMed · Cited by 368
Regulatory and molecular aspects of mammalian amino acid transport
McGivan, J. D., & Pastor-Anglada, M. (1994) · Biochemical Journal · doi:10.1042/bj2990321 · Cited by 368
Krause, B. J., Souvatzoglou, M., Tuncel, M., Herrmann, K., Buck, A. K., Praus, C., Schuster, T., Geinitz, H., Treiber, U., & Schwaiger, M. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0581-4 · Cited by 367
Catana, C., Wu, Y., Judenhofer, M. S., Qi, J., Pichler, B. J., & Cherry, S. R. (2006) · PubMed · Cited by 350
Synthesis and evaluation of (18)F-labeled choline analogs as oncologic PET tracers.
DeGrado, T. R., BALDWIN, S. W., Wang, S., Orr, M. D., Liao, R., Friedman, H. S., Reiman, R. E., Price, D. T., & Coleman, R. E. (2001) · PubMed · Cited by 329
Kaschten, B., Stevenaert, A., Sadzot, B., Deprez, M., Degueldre, C., Fiore, G. D., Luxen, A., & Reznik, M. (1998) · PubMed · Cited by 327
Menendez, J. A., Vellon, L., Mehmi, I., Oza, B. P., Ropero, S., Colomer, R., & Lupu, R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403390101 · Cited by 327
Identification and characterization of the high-affinity choline transporter
Okuda, T., Haga, T., Kanai, Y., Endou, H., Ishihara, T., & Katsura, I. (2000) · Nature Neuroscience · doi:10.1038/72059 · Cited by 323
Meisamy, S., Bolan, P. J., Baker, E. H., Bliss, R., Gulbahce, E. H., Everson, L. I., Nelson, M. T., Emory, T. H., Tuttle, T. M., Yee, D., et al. (2004) · Radiology · doi:10.1148/radiol.2332031285 · Cited by 320
Ott, K., Fink, U., Becker, K., Stahl, A., Dittler, H.-J., Busch, R., Stein, H., Lordick, F., Link, T., Schwaiger, M., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.06.574 · Cited by 318
Self-citationCholine Transport for Phospholipid Synthesis
Michel, V., Yuan, Z., Ramsubir, S., & Bakovic, M. (2006) · Experimental Biology and Medicine · doi:10.1177/153537020623100503 · Cited by 317
O-(2-[18F]fluoroethyl)-l-tyrosine: uptake mechanisms and clinical applications
Langen, K.-J., Hamacher, K., Weckesser, M., Floeth, F., Stoffels, G., Bauer, D., Coenen, H. H., & Pauleit, D. (2006) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2006.01.002 · Cited by 316
Cimitan, M., Bortolus, R., Morassut, S., Canzonieri, V., Garbeglio, A., Baresic, T., Borsatti, E., Drigo, A., & Trovò, M. G. (2006) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-006-0150-2 · Cited by 312
Glycolysis in cancer: A potential target for therapy
Gatenby, R. A., & Gillies, R. J. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.03.021 · Cited by 304
Evaluation of [18F]-choline PET/CT for staging and restaging of prostate cancer
Husarik, D. B., Miralbell, R., Dubs, M., John, H., Giger, O. T., Gelet, A., Cservenyàk, T., & Hany, T. F. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0552-9 · Cited by 295
11C-acetate PET imaging in prostate cancer
Morris, M. J., & Scher, H. I. (2007) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-006-0281-5 · Cited by 294
Value of O-(2-[18F]fluoroethyl)-l-tyrosine PET for the diagnosis of recurrent glioma
P�pperl, G., G�tz, C., Rachinger, W., Gildehaus, F., Tonn, J. C., & Tatsch, K. (2004) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-004-1590-1 · Cited by 293
Delineation of Brain Tumor Extent with [11C]l-Methionine Positron Emission Tomography
Kracht, L. W., Miletic, H., Busch, S., Jacobs, A. H., Voges, J., Hoevels, M., Klein, J. C., Herholz, K., & Heiss, W.-D. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0262 · Cited by 292
System L: heteromeric exchangers of large, neutral amino acids involved in directional transport
Verrey, F. (2003) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-002-0973-z · Cited by 284
Schuster, D. M., Votaw, J. R., Nieh, P. T., Yu, W., Nye, J. A., Master, V. A., Bowman, F. D., Issa, M. M., & Goodman, M. M. (2007) · PubMed · Cited by 275
Brain tumour imaging with PET: a comparison between [ 18 F]fluorodopa and [ 11 C]methionine
Becherer, A., Karanikas, G., Szab�, M., Zettinig, G., Asenbaum, S., Marosi, C., Henk, C., Wunderbaldinger, P., Czech, T., Wadsak, W., et al. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-003-1259-1 · Cited by 266
Swisher, S. G., Erasmus, J., Maish, M., Correa, A. M., Macapinlac, H., Ajani, J. A., Cox, J. D., Komaki, R. R., Hong, D., Lee, H. K., et al. (2004) · Cancer · doi:10.1002/cncr.20585 · Cited by 262
In Vivo Magnetic Resonance Spectroscopy in Cancer
Gillies, R. J., & Morse, D. L. (2005) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.7.060804.100411 · Cited by 261
Van den Abbeele, A. D., & Badawi, R. D. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(02)80604-9 · Cited by 257
Identification of LAT4, a Novel Amino Acid Transporter with System L Activity
Bodoy, S., Martín, L., Zorzano, A., Palacín, M., Estévez, R., & Bertran, J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m408638200 · Cited by 248
Comparison of 18F-FDG and 11C-methionine for PET-guided stereotactic brain biopsy of gliomas.
Pirotte, B. J. M., Goldman, S., Massager, N., David, P., Wikler, D., Vandesteene, A., Salmon, I. J., Brotchi, J., & Levivier, M. (2004) · PubMed · Cited by 248
Farsad, M., Schiavina, R., Castellucci, P., Nanni, C., Corti, B., Martorana, G. E., Canini, R., Grigioni, W. F., Boschi, S., Marengo, M., et al. (2005) · PubMed · Cited by 247
Hoekstra, C. J., Stroobants, S. G., Smit, E. F., Vansteenkiste, J., van Tinteren, H., Postmus, P. E., Golding, R. P., Biesma, B., Schramel, F. J. H. M., van Zandwijk, N., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.1189 · Cited by 247
Control of liver 6-phosphofructokinase by fructose 2,6-bisphosphate and other effectors.
Van Schaftingen, E., Jett, M. F., Hue, L., & Hers, H. G. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.6.3483 · Cited by 246
Direct measurement of brain glucose concentrations in humans by 13C NMR spectroscopy.
Gruetter, R., Novotny, E. J., Boulware, S. D., Rothman, D. L., Mason, G. F., Shulman, G. I., Shulman, R. G., & Tamborlane, W. V. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.3.1109 · Cited by 242
Grosu, A., Weber, W., Riedel, E., et al. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.01.045 · Cited by 242
Self-citationYoshioka, K., Takahashi, H., Homma, T., Saito, M., Oh, K.-B., Nemoto, Y., & Matsuoka, H. (1996) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(95)00153-0 · Cited by 240
L‐type amino acid transporter 1 as a potential molecular target in human astrocytic tumors
Nawashiro, H., Otani, N., Shinomiya, N., Fukui, S., Ooigawa, H., Shima, K., Matsuo, H., Kanai, Y., & Endou, H. (2006) · International Journal of Cancer · doi:10.1002/ijc.21866 · Cited by 236
Cascini, G. L., Avallone, A., Delrio, P., Guida, C., Tatangelo, F., Marone, P., Aloj, L., Martinis, F. D., Comella, P., Parisi, V., et al. (2006) · PubMed · Cited by 231
Babu, E., Kanai, Y., Chairoungdua, A., Kim, D. K., Iribe, Y., Tangtrongsup, S., Jutabha, P., Li, Y., Ahmed, N., Sakamoto, S., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305221200 · Cited by 229
Limburg, K. E., & Moran, M. A. (1986) · Springer Series on Environmental Management · doi:10.1007/978-1-4612-4874-3_6 · Cited by 223
Hara, T., Kosaka, N., & Kishi, H. (2002) · PubMed · Cited by 214
Structure and function of choline kinase isoforms in mammalian cells
Aoyama, C., Liao, H., & Ishidate, K. (2004) · Progress in Lipid Research · doi:10.1016/j.plipres.2003.12.001 · Cited by 213
Van Laere, K., Ceyssens, S., Van Calenbergh, F., de Groot, T., Menten, J., Flamen, P., Bormans, G., & Mortelmans, L. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-004-1564-3 · Cited by 212
de Sande, T. V., Schrijver, E. D., Heyns, W., Verhoeven, G., & Swinnen, J. V. (2002) · PubMed · Cited by 209
Thompson, J. E., & Thompson, C. B. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.01.103 · Cited by 206
Shoup, T. M., Olson, J. J., Hoffman, J. M., Votaw, J. R., Eshima, D., Eshima, L., Camp, V. M., Stabin, M. G., Votaw, D. B., & Goodman, M. M. (1999) · PubMed · Cited by 204
Schöder, H., Herrmann, K., Gönen, M., Hricak, H., Eberhard, S., Scardino, P., Scher, H. I., & Larson, S. M. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0249 · Cited by 202
Evilevitch, V., Weber, W., Tap, W. D., Allen-Auerbach, M., Chow, K., Nelson, S. D., Eilber, F. R., Eckardt, J. J., Elashoff, R. M., Phelps, M. E., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1762 · Cited by 199
Self-citationMazaheri, Y., Shukla-Dave, A., Hricak, H., Fine, S. W., Zhang, J., Inurrigarro, G., Moskowitz, C. S., Ishill, N. M., Reuter, V. E., Touijer, K., et al. (2008) · Radiology · doi:10.1148/radiol.2462070368 · Cited by 199
Positron Emission Tomography for Radiation Treatment Planning
Grosu, A., Piert, M., Weber, W., Jeremic, B. M., Picchio, M., Schratzenstaller, U., Zimmermann, F. B., Schwaiger, M., & Molls, M. (2005) · Strahlentherapie und Onkologie · doi:10.1007/s00066-005-1422-7 · Cited by 197
Self-citationMethionine uptake by tumor tissue: a microautoradiographic comparison with FDG.
Kubota, R., Kubota, K., Yamada, S., et al. (1995) · PubMed · Cited by 196
Bui, T., & Thompson, C. B. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.05.012 · Cited by 195
A real-time method of imaging glucose uptake in single, living mammalian cells
Yamada, K., Saito, M., Matsuoka, H., & Inagaki, N. (2007) · Nature Protocols · doi:10.1038/nprot.2007.76 · Cited by 195
Pöpperl, G., Kreth, F. W., Herms, J. W., Koch, W., Mehrkens, J. H., Gildehaus, F. J., Kretzschmar, H. A., Tonn, J. C., & Tatsch, K. (2006) · PubMed · Cited by 189
Stadlbauer, A., Gruber, S., Nimsky, C., Fahlbusch, R., Hammen, T., Buslei, R., Tomandl, B., Moser, E., & Ganslandt, O. (2006) · Radiology · doi:10.1148/radiol.2382041896 · Cited by 186
Ishiwata, K., Kubota, K., Murakami, M., et al. (1993) · PubMed · Cited by 186
Molecular imaging using hyperpolarized 13C
Golman, K., Olsson, L. E., Axelsson, O., Månsson, S., Karlsson, M., & Petersson, J. S. (2003) · The British Journal of Radiology · doi:10.1259/bjr/26631666 · Cited by 184
13C imaging—a new diagnostic platform
Månsson, S., Johansson, E., Magnusson, P., Chai, C.-M., Hansson, G., Petersson, J. S., Ståhlberg, F., & Golman, K. (2006) · European Radiology · doi:10.1007/s00330-005-2806-x · Cited by 181
Phosphorylcholine: a novel second messenger essential for mitogenic activity of growth factors.
Cuadrado, A., Carnero, A., Dolfi, F., Jiménez, B., & Lacal, J. C. (1993) · PubMed · Cited by 180
Glucose Metabolism Heterogeneity in Human and Mouse Malignant Glioma Cell Lines
Griguer, C. E., Oliva, C. R., & Gillespie, G. Y. (2005) · Journal of Neuro-Oncology · doi:10.1007/s11060-004-6404-6 · Cited by 178
Blum, R., Jacob‐Hirsch, J., Amariglio, N., Rechavi, G., & Kloog, Y. (2005) · PubMed · Cited by 178
Zhou, W., Han, W. F., Landree, L. E., Thupari, J. N., Pinn, M. L., Bililign, T., Kim, E. K., Vadlamudi, A., Medghalchi, S. M., Meskini, R. E., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3439 · Cited by 178
History of the Pasteur effect and its pathobiology
Racker, E. (1974) · Molecular and Cellular Biochemistry · doi:10.1007/bf01874168 · Cited by 172
Ras transformation requires metabolic control by 6-phosphofructo-2-kinase
Telang, S., Yalcin, A., Clem, A. L., Bucala, R., Lane, A. N., Eaton, J. W., & Chesney, J. (2006) · Oncogene · doi:10.1038/sj.onc.1209709 · Cited by 168
Effects of hypoxia on tumor metabolism
Kim, J., Gao, P., & Dang, C. V. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9060-4 · Cited by 166
Ceresoli, G. L., Chiti, A., Zucali, P. A., Rodari, M., Lutman, R. F., Salamina, S., Incarbone, M., Alloisio, M., & Santoro, A. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.8999 · Cited by 161
Blum, R., Jacob-Hirsch, J., Amariglio, N., Rechavi, G., & Kloog, Y. (2005) · Cancer Research · doi:10.1158/0008-5472.999.65.3 · Cited by 161
Vāvere, A. L., Kridel, S. J., Wheeler, F. B., & Lewis, J. S. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.046672 · Cited by 154
Pirzkall, A., Li, X., Oh, J., Chang, S. M., Berger, M. S., Larson, D. A., Verhey, L., Dillon, W. P., & Nelson, S. J. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2003.08.023 · Cited by 152
de Molina, A. R., Báñez-Coronel, M., Gutiérrez, R., Rodríguez-González, A., Olmeda, D., Megías, D., & Lacal, J. C. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0489 · Cited by 146
Rau, F. C., Weber, W., Wester, H., Herz, M., Becker, I., Krüger, A., Schwaiger, M., & Senekowitsch–Schmidtke, R. (2002) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-002-0821-6 · Cited by 141
Self-citationTechnology Insight: advances in molecular imaging and an appraisal of PET/CT scanning
Weber, W., Grosu, A., & Czernin, J. G. (2008) · Nature Clinical Practice Oncology · doi:10.1038/ncponc1041 · Cited by 131
Self-citationMR imaging and MR spectroscopic imaging in the pre-treatment evaluation of prostate cancer
Hricak, H. (2005) · British Journal of Radiology · doi:10.1259/bjr/11253478 · Cited by 129
6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase and tumor cell glycolysis
Chesney, J. A. (2006) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/01.mco.0000241661.15514.fb · Cited by 128
Kaira, K., Oriuchi, N., Otani, Y., et al. (2007) · CHEST Journal · doi:10.1378/chest.06-2160 · Cited by 127
Sunaga, N., Oriuchi, N., Kaira, K., Yanagitani, N., Tomizawa, Y., Hisada, T., Ishizuka, T., Endo, K., & Mori, M. (2007) · Lung Cancer · doi:10.1016/j.lungcan.2007.08.012 · Cited by 126
Monitoring chemotherapy and radiotherapy of solid tumors
Weber, W., & Wieder, H. A. (2006) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-006-0133-3 · Cited by 124
Self-citationRiedl, C. C., Akhurst, T., Larson, S. M., Stanziale, S. F., Tuorto, S., Bhargava, A., Hricak, H., Klimstra, D., & Fong, Y. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.106.037291 · Cited by 123
Cerebral metabolism of L-[2-18F]fluorotyrosine, a new PET tracer of protein synthesis.
Coenen, H. H., Kling, P., & Stöcklin, G. (1989) · PubMed · Cited by 122
Chemotherapy Response Evaluation with 18F-FDG PET in Patients with Non-Small Cell Lung Cancer
de Geus‐Oei, L., van der Heijden, E. H. F. M., Visser, E. P., Hermsen, R., van Hoorn, B. A., Timmer-Bonte, J. N. H., Willemsen, A. T. M., Pruim, J., Corstens, F. H. M., Krabbe, P. F. M., et al. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.043414 · Cited by 121
Outcome and Cost of Craniotomy Performed to Treat Tumors in Regional Academic Referral Centers
Long, D. M., Gordon, T. A., Bowman, H. M., Etzel, A., Burleyson, G. P., Betchen, S. A., Garonzik, I. M., & Brem, H. (2003) · Neurosurgery · doi:10.1227/01.neu.0000057745.48813.93 · Cited by 112
F-Dopa as an amino acid tracer to detect brain tumors.
Heiss, W., Wienhard, K., Wagner, R. L., Lanfermann, H., Thiel, A., Herholz, K., & Pietrzyk, U. (1996) · PubMed · Cited by 112
Derlon, J.-M., Chapon, F., Noël, M.-H., Khouri, S., Benali, K., Petit-Taboué, M.-C., Houtteville, J. P., Chajari, M., & Bouvard, G. (2000) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590000260 · Cited by 110
Kaira, K., Oriuchi, N., Otani, Y., Shimizu, K., Tanaka, S., Imai, H., Yanagitani, N., Sunaga, N., Hisada, T., Ishizuka, T., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1294 · Cited by 108
Yamada, Y., Uchida, Y., Tatsumi, K., Yamaguchi, T., Kimura, H., Kitahara, H., & Kuriyama, T. (1998) · PubMed · Cited by 107
In vivo uptake of [11C]choline does not correlate with cell proliferation in human prostate cancer
Breeuwsma, A. J., Pruim, J., Jongen, M. M., Suurmeijer, A. J. H., Vaalburg, W., Nijman, R. J. M., & de Jong, I. J. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-004-1741-4 · Cited by 107
PET with O-(2-18F-Fluoroethyl)-L-Tyrosine in peripheral tumors: first clinical results.
Pauleit, D. O., Stoffels, G., Schaden, W., Hamacher, K., Bauer, D., Tellmann, L., Herzog, H. R., Bröer, S., Coenen, H. H., & Langen, K. (2005) · PubMed · Cited by 106
Integrating PET and PET/CT into the risk-adapted therapy of lymphoma.
Kasamon, Y. L., Jones, R. J., & Wahl, R. L. (2007) · PubMed · Cited by 101
Evaluation of brain tumor metabolism with [11C]choline PET and 1H-MRS
Utriainen, M., Komu, M. E. S., Vuorinen, V., et al. (2003) · Journal of Neuro-Oncology · doi:10.1023/a:1023342516925 · Cited by 100
[11C]methionine PET, histopathology, and survival in primary brain tumors and recurrence.
Ceyssens, S. K., Laere, K. V., de Groot, T., Goffin, J., Bormans, G. M., & Mortelmans, L. (2006) · PubMed · Cited by 98
Tan, M. C. B., Linehan, D. C., Hawkins, W. G., Siegel, B. A., & Strasberg, S. M. (2007) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-007-0218-8 · Cited by 93
18F-FET PET compared with 18F-FDG PET and CT in patients with head and neck cancer.
Pauleit, D. O., Zimmermann, A. C., Stoffels, G., Bauer, D., Risse, J. H., Flüß, M. O., Hamacher, K., Coenen, H. H., & Langen, K. (2006) · PubMed · Cited by 91
18F alpha-methyl tyrosine PET studies in patients with brain tumors.
Inoue, T., Shibasaki, T., Oriuchi, N., Aoyagi, K., Tomiyoshi, K., Amano, S., Mikuni, M., Ida, I., Aoki, J., & Endo, K. (1999) · PubMed · Cited by 91
Fluorine-18-FDG PET and iodine-123-IMT SPECT in the evaluation of brain tumors.
Weber, W., Bartenstein, P., Groß, M. W., Kinzel, D., Daschner, H., Feldmann, H. J., Reidel, G., Ziegler, S. I., Lumenta, C. B., Molls, M., et al. (1997) · PubMed · Cited by 89
Self-citationHaase‐Kohn, C., Bergmann, R., Füchtner, F., Hoepping, A., & Pietzsch, J. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.043620 · Cited by 84
Brain tumors: L-[1-C-11]tyrosine PET for visualization and quantification of protein synthesis rate.
Pruim, J., Willemsen, A. T. M., Molenaar, W. M., van Waarde, A., Paans, A. M. J., Heesters, M. A. A. M., Go, K. G., Visser, G. M., Franssen, E. J. F., & Vaalburg, W. (1995) · Radiology · doi:10.1148/radiology.197.1.7568827 · Cited by 83
Proton MR spectroscopy of the brain at 3 T: an update
Costanzo, A. D., Trojsi, F., Tosetti, M., Schirmer, T., Lechner, S. M., Popolizio, T., & Scarabino, T. (2007) · European Radiology · doi:10.1007/s00330-006-0546-1 · Cited by 82
Liu, W., Su, H. C., Hildebrandt, I. J., Phelps, M. E., Czernin, J. G., & Weber, W. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1824 · Cited by 82
Self-citationAn In vivo Tumor Model Exploiting Metabolic Response as a Biomarker for Targeted Drug Development
Cullinane, C. M., Dorow, D. S., Kansara, M., Conus, N. M., Binns, D., Hicks, R. J., Ashman, L. K., McArthur, G. A., & Thomas, D. M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2285 · Cited by 79
Bansal, A., Shu-yan, W., Hara, T., Harris, R. A., & DeGrado, T. R. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-008-0736-y · Cited by 78
Nakanishi, K., Ogata, S., Matsuo, H., Kanai, Y., Endou, H., Hiroi, S., Tominaga, S. O., Aida, S., Kasamatsu, H., & Kawai, T. (2007) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-007-0457-9 · Cited by 78
Kole, A. C., Nieweg, O., Pruim, J., Paans, A. M., Plukker, J. T. H. M., Hoekstra, H., Koops, H. S., & Vaalburg, W. (1997) · PubMed · Cited by 71
Sang, J., Lim, Y. P., Panzica, M. A., et al. (1995) · PubMed · Cited by 70
Quantification of ATP‐producing and consuming processes of Ehrlich ascites tumour cells
Müller, M. R., Siems, W., Buttgereit, F., Dumdey, R., & Rapoport, S. M. (1986) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1986.tb10496.x · Cited by 68
High expression of L-type amino acid transporter 1 in infiltrating glioma cells
Nawashiro, H., Otani, N., Uozumi, Y., Ooigawa, H., Toyooka, T., Suzuki, T., Katoh, H., Tsuzuki, N., Ohnuki, A., Shima, K., et al. (2005) · Brain Tumor Pathology · doi:10.1007/s10014-005-0188-z · Cited by 68
1-11C-Acetate Kinetics of Prostate Cancer
Schiepers, C. W., Hoh, C. K., Nuyts, J. L., Seltzer, M., Wu, C., Huang, S., & Dahlbom, M. L. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.044453 · Cited by 66
Inoue, T., Kim, E. E., Wong, F. C., Yang, D. J., Bassa, P., Wong, W., Korkmaz, M., Tansey, W., Hicks, K., & Podoloff, D. A. (1996) · PubMed · Cited by 65
In vivo proton magnetic resonance spectroscopy of breast lesions: an update
Tse, G. M.-K., Yeung, D. K. Y., King, A. D., Cheung, H. S., & Yang, W. T. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9412-8 · Cited by 59
Nettelbladt, O., Sundin, A., Valind, S.-O., Gustafsson, G. R., Lamberg, K., Långström, B., & Björnsson, E. H. (1998) · PubMed · Cited by 59
Gaugitsch, H. W., Prieschl, E. E., Kalthoff, F., Huber, N. E., & Baumruker, T. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49906-7 · Cited by 57
High‐speed 3T MR spectroscopic imaging of prostate with flyback echo‐planar encoding
Chen, A. P., Cunningham, C. H., Öztürk-Işık, E., Xu, D., Hurd, R. E., Kelley, D. A. C., Pauly, J. M., Kurhanewicz, J. V., Nelson, S. J., & Vigneron, D. B. (2007) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.20916 · Cited by 50
Erasmus, J. J., & Munden, R. F. (2006) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2006.09.005 · Cited by 47
The role of FDG PET in the management of lymphoma: what is the evidence base?
Kirby, A. M., & Mikhaeel, N. G. (2007) · Nuclear Medicine Communications · doi:10.1097/mnm.0b013e3280895e23 · Cited by 46
Chen, J., Huang, S., Li, T., & Chen, X.-L. (2006) · Neuroradiology · doi:10.1007/s00234-006-0066-3 · Cited by 46
Choline kinase alpha in cancer prognosis and treatment
Glunde, K., & Bhujwalla, Z. M. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70289-9 · Cited by 44
FDG and L-[1-11C]-tyrosine imaging of soft-tissue tumors before and after therapy.
Kole, A. C., Plaat, B. E. C., Hoekstra, H. J., Vaalburg, W., & Molenaar, W. M. (1999) · PubMed · Cited by 42
A new view of K+-induced contraction in rat aorta: the role of Ca2+ binding
Kravtsov, G. M., Bruce, I. C., Wong, T., & Kwan, C. (2003) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-003-1096-x · Cited by 40
Sutinen, E., Jyrkkiö, S. M., Grönroos, T. J., Haaparanta‐Solin, M., Lehikoinen, P., & Någren, K. (2001) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590100548 · Cited by 35
Shikano, N., Kanai, Y., Kawai, K., Inatomi, J., Kim, D. K., Ishikawa, N., & Endou, H. (2003) · PubMed · Cited by 30
L-Type Amino Acid Transporter-1 Expressed in Human Astrocytomas, U343MGa
Asano, S., Kameyama, M., Oura, A., Morisato, A., 酒井, 秀., Tabuchi, Y., Chairoungdua, A., Endou, H., & Kanai, Y. (2007) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.30.415 · Cited by 24
Dresel, S. H. J., & Schlag, P. M. (2008) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-540-31203-1_9 · Cited by 3
Cited by
A Molecular Imaging Primer: Modalities, Imaging Agents, and Applications
James, M. L., & Gambhir, S. S. (2012) · Physiological Reviews · doi:10.1152/physrev.00049.2010 · Cited by 1,140
Lactate: A Metabolic Key Player in Cancer
Hirschhaeuser, F., Sattler, U. G. A., & Mueller-Klieser, W. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1457 · Cited by 1,090
Glucose transporters in cancer – from tumor cells to the tumor microenvironment
Ancey, P., Contat, C., & Meylan, E. (2018) · The FEBS Journal · doi:10.1111/febs.14577 · Cited by 514
Mechanisms of temozolomide resistance in glioblastoma - a comprehensive review
Singh, N., Miner, A., Hennis, L., & Mittal, S. (2020) · Cancer Drug Resistance · doi:10.20517/cdr.2020.79 · Cited by 398
The fate of chemoresistance in triple negative breast cancer (TNBC)
O’Reilly, E. A., Gubbins, L., Sharma, S., Tully, R., Guang, M. H. Z., Weiner-Gorzel, K., McCaffrey, J., Harrison, M., Furlong, F., Kell, M., et al. (2015) · BBA Clinical · doi:10.1016/j.bbacli.2015.03.003 · Cited by 377
Metadata
- Authors
- Plathow, C., & Weber, W. A.
- Venue
- Journal of Nuclear Medicine
- Publisher
- Society of Nuclear Medicine
- Published
- 2008-06
- Volume
- 49
- Issue
- Suppl 2
- Pages
- 43S-63S
- ISSN
- 0161-5505 (ISSN-L)
- 2159-662X
- OpenAlex
- W2031022390
- Cited by
- 328
- References
- 165
- FWCI
- 7.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.